teriflunomide mylan
mylan pharmaceuticals limited - teriflunomide - multippel sklerose, relapsing-remitting - immunsuppressive - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).
teriflunomide accord
accord healthcare s.l.u. - teriflunomide - multippel sklerose, relapsing-remitting - immunosuppressants, selektiv immunosuppressants - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).
jaypirca
eli lilly nederland b.v. - pirtobrutinib - lymfom, mantelcelle - protein kinase hemmere - treatment of mantle cell lymphoma (mcl).
galvus 50 mg
2care4 aps - vildagliptin - tablett - 50 mg
januvia 100 mg
farmagon - sitagliptinfosfatmonohydrat - tablett, filmdrasjert - 100 mg
januvia 25 mg
orifarm as - sitagliptinfosfatmonohydrat - tablett, filmdrasjert - 25 mg
januvia 100 mg
orifarm as - sitagliptinfosfatmonohydrat - tablett, filmdrasjert - 100 mg
xelevia 25 mg
orifarm as - sitagliptinfosfatmonohydrat - tablett, filmdrasjert - 25 mg
januvia 50 mg
orifarm as - sitagliptinfosfatmonohydrat - tablett, filmdrasjert - 50 mg
adenuric 80 mg
2care4 aps - febuksostat - tablett, filmdrasjert - 80 mg